ViRexx Medical Corp. Announces 2008 Second Quarter Results
EDMONTON, ALBERTA--(Marketwire - August 14, 2008) - ViRexx Medical Corp. (TSX: VIR) (AMEX: REX), company focused on developing innovative-targeted therapeutic products that offer better quality of life and a renewed hope for living. Its platform technologies include product candidates for the treatment of Hepatitis B, Hepatitis C, avian influenza viral infections, biodefence and nanoparticle applications, select solid tumors and late-stage ovarian cancer, today announced its financial and operational results for the three-month period ended June 30, 2008.